Dash Acquisitions’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Dash Acquisitions's BMY Position: Q2 2026 in Review
Dash Acquisitions increased its Bristol-Myers Squibb (BMY) stake by 0.46% in Q2 2026, buying an estimated $1.44K and bringing the position to 5,425 shares worth $346K. The position accounts for 0.07% of the portfolio, ranked #57.
Dash Acquisitions first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. 2,516 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Dash Acquisitions held 5,425 shares of Bristol-Myers Squibb worth $346K as of Q2 2026.
- Dash Acquisitions bought 25 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.44K.
- Bristol-Myers Squibb made up 0.07% of Dash Acquisitions's portfolio in Q2 2026, its #57 holding.
- Dash Acquisitions first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
- 2,516 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Dash Acquisitions's 13F filing for Q2 2026, filed 13 Aug 2026.